Form 4: USANA Director Converts RSUs to Common Stock
Insider Transaction Report
USANA Health Sciences Director J Scott Nixon converted 1,057 restricted stock units into common stock, increasing his direct share ownership.
Summary
- J Scott Nixon, a Director of USANA Health Sciences Inc. (USNA), reported a change in beneficial ownership.
- On October 23, 2025, Nixon exercised 1,057 Restricted Stock Units (RSUs) into 1,057 shares of USNA common stock.
- Each RSU represents a contingent right to receive one share of USNA common stock.
- Following this transaction, Nixon directly beneficially owns 7,698 shares of common stock.
- Nixon also directly beneficially owns 2,115 Restricted Stock Units.
- The remaining Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
Sentiment
Score: 7
Explanation: A director's conversion of restricted stock units into common stock and subsequent increase in direct share ownership is generally viewed as a neutral to slightly positive event, indicating continued alignment with shareholder interests.
Positives
- A director increased their direct ownership of common stock through the conversion of restricted stock units, aligning their interests further with shareholders.
Future Outlook
The filing indicates future vesting dates for the remaining Restricted Stock Units held by the director, with 25% vesting on January 22, 2026, and April 23, 2026.
Industry Context
This filing is a routine insider transaction report (Form 4) and does not provide information related to broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: The transaction increases the director's direct ownership, potentially signaling confidence and aligning management's interests with long-term shareholder value.
Next Steps
- Future vesting of remaining Restricted Stock Units on January 22, 2026, and April 23, 2026.
Key Dates
| Date | Description |
|---|---|
| 07/24/2025 | Vesting date for 25% of Restricted Stock Units |
| 10/23/2025 | Transaction date for the conversion of 1,057 Restricted Stock Units into common stock and vesting date for 25% of Restricted Stock Units |
| 10/27/2025 | Signature date of the reporting person's attorney-in-fact |
| 01/22/2026 | Vesting date for 25% of Restricted Stock Units |
| 04/23/2026 | Vesting date for 25% of Restricted Stock Units |
Recommendation
holdThe filing reports a routine conversion of restricted stock units by a director, which is a standard compensation event and does not provide new fundamental information to alter an investment recommendation. It reflects continued insider ownership rather than a discretionary purchase or sale based on new insights.
Keywords
USANA Health Sciences, USNA, Form 4, Insider Transaction, Director, Restricted Stock Units, RSU Conversion, Common Stock, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.